Paul A. Wagner

Paul A. Wagner discloses dealings in Forte Biosciences, Inc. to SEC (Form 4). In total, 45 filings cover trades dated from 25 June 2020 to 27 August 2026.

The open-market side counts 14 purchases for €258k alongside 1 sale for €3.7M. On balance, insiders were net sellers of €3.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 15 share grants and 14 option exercises.

The median purchase comes to €6,857. No cluster: in 14 purchases, no other insider of the company bought within 30 days.

The record was last updated on 27 August 2026 with a transaction in Forte Biosciences, Inc. The latest purchase dates back some time: it was published 1,039 days ago, on 20 December 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.